Cargando…

Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers

IMPORTANCE: Accurate risk prediction models using routinely measured biomarkers—eg, carbohydrate antigen 19-9 (CA19-9) and bilirubin serum levels—for pancreatic cancer could facilitate early detection of pancreatic cancer and prevent potentially unnecessary diagnostic tests for patients at low risk....

Descripción completa

Detalles Bibliográficos
Autores principales:	Boyd, Lenka N. C., Ali, Mahsoem, Comandatore, Annalisa, Garajova, Ingrid, Kam, Laura, Puik, Jisce R., Fraga Rodrigues, Stephanie M., Meijer, Laura L., Le Large, Tessa Y. S., Besselink, Marc G., Morelli, Luca, Frampton, Adam, van Laarhoven, Hanneke W. M., Giovannetti, Elisa, Kazemier, Geert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463099/ https://www.ncbi.nlm.nih.gov/pubmed/37639271 http://dx.doi.org/10.1001/jamanetworkopen.2023.31197

Ejemplares similares

The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach
por: Boyd, Lenka N. C., et al.
Publicado: (2022)

hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients
por: Meijer, Laura L., et al.
Publicado: (2016)

Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct Tumors
por: Meijer, Laura L., et al.
Publicado: (2019)

Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study
por: Boyd, Lenka N. C., et al.
Publicado: (2023)

Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data
por: Boyd, Lenka N.C., et al.
Publicado: (2022)

Novel Strategies to Address Critical Challenges in Pancreatic Cancer
por: Puik, Jisce R., et al.
Publicado: (2022)

Factors that influence the pancreatic and duodenal microbiome in patients undergoing pancreatic surgery
por: Zwart, Eline S., et al.
Publicado: (2022)

Molecular Mechanisms Underlying the Role of MicroRNAs in the Chemoresistance of Pancreatic Cancer
por: Garajová, Ingrid, et al.
Publicado: (2014)

Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer
por: Comandatore, Annalisa, et al.
Publicado: (2022)

A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease
por: Mato Prado, Mireia, et al.
Publicado: (2023)

Multidrug‐resistant transporter expression does not always result in drug resistance
por: Le Large, Tessa Ya Sung, et al.
Publicado: (2018)

Combined Expression of Plasma Thrombospondin‐2 and CA19‐9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach
por: Le Large, Tessa Y.S., et al.
Publicado: (2020)

Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics
por: Balsano, Rita, et al.
Publicado: (2022)

Omics Analysis of Educated Platelets in Cancer and Benign Disease of the Pancreas
por: Mantini, Giulia, et al.
Publicado: (2020)

Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment
por: Le Large, Tessa Ya Sung, et al.
Publicado: (2019)

ASO Author Reflections: Current Treatment Options for Duodenal Adenocarcinoma—A Call for Collaborative Studies
por: Meijer, Laura L., et al.
Publicado: (2018)

Machine learning models in clinical practice for the prediction of postoperative complications after major abdominal surgery
por: Stam, Wessel T., et al.
Publicado: (2023)

The use of ChatGPT and other large language models in surgical science
por: Janssen, Boris V, et al.
Publicado: (2023)

c-Met as a Target for Personalized Therapy
por: Garajová, Ingrid, et al.
Publicado: (2015)

Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis
por: Meijer, Laura L., et al.
Publicado: (2018)

MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma—a step towards personalized therapy
por: Garajová, Ingrid, et al.
Publicado: (2015)

The use of histopathological subtyping in patients with ampullary cancer: a nationwide analysis
por: de Bakker, Jacob, et al.
Publicado: (2022)

Clinical outcomes of patients with duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinoma
por: Meijer, Laura L, et al.
Publicado: (2020)

Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma
por: Le Large, T. Y. S., et al.
Publicado: (2021)

“Open Sesame?”: Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic Cancer
por: Randazzo, Ornella, et al.
Publicado: (2020)

The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer
por: Zwart, Eline S., et al.
Publicado: (2023)

Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits
por: Rodriguez, Ernesto, et al.
Publicado: (2022)

Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Gregori, Alessandro, et al.
Publicado: (2023)

Pattern of recurrence and survival after D2 right colectomy for cancer: is there place for a routine more extended lymphadenectomy?
por: Palmeri, Matteo, et al.
Publicado: (2022)

The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population‐based analysis
por: Bakens, Maikel J., et al.
Publicado: (2016)

Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers
por: Mantini, G., et al.
Publicado: (2020)

Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options
por: Sluiter, Nina, et al.
Publicado: (2016)

Focus on Therapeutic Options for Surgically Resectable Pancreatic Adenocarcinoma Based on Novel Biomarkers
por: Olivari, Alessandro, et al.
Publicado: (2023)

Delayed Versus Immediate Start of Chemotherapy in Asymptomatic Patients With Advanced Cancer: A Meta-Analysis
por: Augustinus, Simone, et al.
Publicado: (2023)

It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer
por: Garajová, Ingrid, et al.
Publicado: (2022)

Development of a set of patient reported outcome measures for patients with benign liver tumours and cysts: patient focus groups and systematic review
por: Furumaya, Alicia, et al.
Publicado: (2022)

Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer
por: van der Geest, Lydia G. M., et al.
Publicado: (2017)

Ileo-colic intra-corporeal anastomosis during robotic right colectomy: a systematic literature review and meta-analysis of different techniques
por: Guadagni, Simone, et al.
Publicado: (2021)

A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists
por: Garajová, Ingrid, et al.
Publicado: (2023)

The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth
por: Manoukian, Paul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6p1b1mha09q1vp9teqf5nq75mg